Siegfried: Closing conditions for acquisition of three BASF sites satisfied
Advertisement
All closing conditions on the path toward Siegfried‘s acquisition of BASF’s pharmaceutical supply business have been fulfilled. They include regulatory assurance issued by Swissmedic that the necessary approval for the Evionnaz production site will be provided in time for the closing.
Siegfried assumes that the agreements between Siegfried and BASF (closing) and the connected transfer of the chemical-pharmaceutical production sites in France, Germany and Switzerland will be enforced as planned on September 30, 2015.